Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Seminars in Oncology|January 14, 1998
Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary resultsP Chougule, H Wanebo, W Akerley, et al.
American Journal of Surgery|November 28, 1997
Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancerH J Wanebo, P Chougule, W L Akerley, et al.
Seminars in Radiation Oncology|April 21, 1999
Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II studyP B Chougule, M S Akhtar, W Akerley, et al.
Annals of Surgical Oncology|September 25, 2001
Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV)H Wanebo, P Chougule, N Ready, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Paclitaxel and concurrent radiation for locally advanced pancreatic cancerH Safran, T Moore, D Iannitti, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Paclitaxel and concurrent radiation for gastric cancerH Safran, H J Wanebo, P J Hesketh, et al.
Experimental and Molecular Pathology|March 27, 2013
Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technologyK Perez, R Walsh, K Brilliant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I studyH Safran, T P King, H Choy, et al.
American Journal of Clinical Oncology|October 5, 2001
Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinomaH Safran, M Steinhoff, S Mangray, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancerJ V Heymach, D H Johnson, F R Khuri, et al.
Pageof 4